Meanwhile, Israeli companies are looking at marijuana “in terms of classic drug development.” Such approaches and the ability to provide medicine in accurate doses and strengths is necessary before most doctors will be comfortable prescribing medication derived from botanicals such as cannabis, Himmel said.